SecurityGSK / GlaxoSmithKline plc
InstitutionFarmers Trust Co
Shares109,230
Value $ 4,404,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Farmers Trust Co reports 12.99% decrease in ownership of GSK / GlaxoSmithKline plc

July 09, 2018 - Farmers Trust Co has filed a 13F-HR form disclosing ownership of 109,230 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $4,404,000 USD as of June 30, 2018. Farmers Trust Co had filed a previous 13F-HR on April 13, 2018 disclosing 125,538 shares of GlaxoSmithKline plc at a value of $4,905,000 USD. This represents a change in shares of -12.99 percent and a change in value of -10.21 percent during the quarter.

Other investors with positions similar to Farmers Trust Co include Foresters Investment Management Company, Inc., Jane Street Group, Llc, CAMG Solamere Management, LLC, Oppenheimer & Co Inc, First Republic Investment Management, Inc., and Woodley Farra Manion Portfolio Management Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.70 109,230 -12.99 4,404 -10.21 -647 146 2.98
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 125,538 7.09 4,905 17.97 310 437 10.51
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.04 117,225 -4.85 4,158 -16.87 -227 -617 -12.33
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.86 123,194 2.07 5,002 -3.90 105 -308 -5.91
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 42.64 120,696 0.09 5,205 2.38 4 117 2.29
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.34 120,592 -1.44 5,084 7.89 -71 443 9.40
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.82 122,352 -1.69 4,712 -12.20 -86 -569 -10.60
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.23 124,456 -1.88 5,367 -2.38 -103 -28 -0.51
2016-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.95 126,843 0.35 5,498 7.28 19 354 6.91
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.45 126,397 29.49 5,125 30.14 1,164 23 0.58
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.40 97,610 730.37 3,938 771.24 3,383 103 22.89
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.02 11,755 -3.57 452 -10.85 -17 -38 -7.41
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.86 12,190 -0.81 507 -10.58 -4 -56 -9.81
2015-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 22,808.78 12,290 87,685.71 567 -11.13 280,001 -280,072 -43,898.37
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 22,808.71 14 -99.91 638 -13.78 -366,673 366,571 49,536.60
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 49.73 16,090 -0.31 740 -14.25 -2 -121 -13.96
2014-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 16,140 863


CUSIP: 37733W105